You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Migraine: A Review of Novel Therapeutics

  • Authors: Teshamae Monteith, MD, FAHS, FAAN; Cristina Tassorelli, MD, PhD
  • CME / CE Released: 10/12/2022
  • Valid for credit through: 10/12/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    Nurses - 1.00 ANCC Contact Hour(s) (0.75 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for neurologists, nurse practitioners, and nurses involved in the care of patients with migraine.

The goal of this activity is that learners will be better able to utilize pharmacologic and non-pharmacologic treatments for the management of migraine.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical data for calcitonin gene-related peptide (CGRP)-targeted therapies studied for the management of migraine 
    • Clinical factors for the identification of patients who may be candidates for a CGRP-targeted therapy for the management of migraine 
    • Factors involved in the identification of patients who are candidates for a non-oral acute migraine therapy 
    • Clinical data for devices used for the management of migraine 
    • Factors involved in the identification of patients who may be candidates for a device-based therapy for the management of migraine 
  • Have greater competence related to
    • The selection of an appropriate CGRP-targeted therapy for the management of migraine 
    • The selection of an appropriate non-oral acute therapy for the management of migraine


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Session Chair

  • Teshamae Monteith, MD, FAHS, FAAN

    Associate Professor of Clinical Neurology
    Chief, Headache Division
    Fellowship Program Director
    University of Miami Miller School of Medicine
    Miami, Florida, United States

    Disclosures

    Teshamae Monteith, MD, FAHS, FAAN, has the following relevant financial relationships:
    Consultant or advisor for: Impel; Lundbeck; Teva
    Research funding from: AbbVie; Amgen; Electrocore; Eli Lilly; Novartis

  • Cristina Tassorelli, MD, PhD

    Full Professor and Chair of Neurology
    Director of the Residency in Neurology Program
    Director of the Department of Brain and Behavioral Sciences
    University of Pavia
    Director, Rehabilitative Neurology Unit
    Headache Science and Neurorehabilitation Research Centre
    IRCCS C. Mondino Foundation
    Pavia, Italy

    Disclosures

    Cristina Tassorelli, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Dompé; Eli Lilly; Lundbeck; Novartis; Teva
    Speaker or member of speakers bureau for: AbbVie; Eli Lilly; Lundbeck; Novartis; Teva
    Research funding from: AbbVie

Editors

  • Meg Monday

    Senior Director, Content Development, Medscape, LLC 

    Disclosures

    Meg Monday has no relevant financial relationships. 

  • Kathy Merlo

    Medical Education Director, Medscape, LLC 

    Disclosures

    Kathy Merlo has no relevant financial relationships.  

Compliance Reviewer/Nurse Planner

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC 

    Disclosures

    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships. 

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.75 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Migraine: A Review of Novel Therapeutics

Authors: Teshamae Monteith, MD, FAHS, FAAN; Cristina Tassorelli, MD, PhDFaculty and Disclosures

CME / CE Released: 10/12/2022

Valid for credit through: 10/12/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

What's the Deal With CGRP-Targeted Therapeutics in Migraine: Acute and Preventive Therapeutics

Listen to learn more about migraine-specific acute and preventive therapies.
Teshamae Monteith, MD, FAHS, FAAN

One Size Doesn't Fit All for the Acute Treatment of Migraine: Beyond Oral Options

Listen to learn more about injectable and intranasal acute treatments for migraine.
Teshamae Monteith, MD, FAHS, FAAN

Is There a Role for Device-Based Therapies in Migraine Care?

Listen to learn more about neuromodulation devices as acute and preventive therapies in migraine.
Cristina Tassorelli, MD, PhD
 

Educational Impact Challenge

The goal of this activity is that learners will be better able to utilize pharmacologic and non-pharmacologic treatments for the management of migraine.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.